| 摘要 |
Compositions and methods comprising proteinase activated receptor antagonists are provided. More particularly, the present invention relates to the use of proteins, peptides and molecules that bind to proteinase activated receptor 2, and inhibit the processes associated with the activation of that receptor. More specifically, the present invention provides novel compositions and methods for the treatment of disorders and diseases such as those associated with abnormal cellular proliferation, angiogenesis, inflammation and cancer.
|
| 申请人 |
ENTREMED, INC.;AGOSTON, GREGORY, E.;HEMBROUGH, TODD, A.;LAVALLEE, THERESA, M.;SHAH, JAMSHED, H.;SUWANDI, LITA;TRESTON, ANTHONY, M. |
发明人 |
AGOSTON, GREGORY, E.;HEMBROUGH, TODD, A.;LAVALLEE, THERESA, M.;SHAH, JAMSHED, H.;SUWANDI, LITA;TRESTON, ANTHONY, M. |
